Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 17/20 | 0.59 |
| ▸ | MAP2K2 | P36507 | 7/20 | 0.51 |
| ▸ | IDO1 | P14902 | 1/20 | 0.51 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | PRKCB | P05771 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.40 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.40 |
| ▸ | STK3 | Q13188 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23851383 | 1.00 | MAP2K1 (0.59) | MAP2K1MAP2K2IDO1AURKAPRKCB | |
| SCHEMBL31376766 | 0.90 | MAP2K1 (0.56) | MAP2K1MAP2K2IDO1AURKAPRKCB | |
| SCHEMBL24196106 | 0.88 | MAP2K1 (0.48) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL31135631 | 0.87 | MAP2K1 (0.50) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL23850846 | 0.87 | MAP2K1 (0.50) | MAP2K1MAP2K2IDO1 | |
| SCHEMBL24195682 | 0.86 | DHODH (0.42) | MAP2K1MAP2K2DHODH | |
| SCHEMBL23851097 | 0.83 | MAP2K1 (0.62) | MAP2K1MAP2K2IDO1DHODH | |
| SCHEMBL31135615 | 0.83 | MAP2K1 (0.62) | MAP2K1MAP2K2IDO1DHODH | |
| SCHEMBL24195910 | 0.82 | MAP2K1 (0.65) | MAP2K1MAP2K2 | |
| SCHEMBL24195795 | 0.82 | MAP2K1 (0.65) | MAP2K1MAP2K2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113473978-B | Cyanoarene-aniline compounds for the treatment of skin disorders | 恩福莱克逊治疗有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119215031-A | Arylaniline and heteroaryl aniline compounds for the treatment of skin cancer | 恩福莱克逊治疗有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-113645964-B | Arylaniline and heteroaryl aniline compounds for fetal treatment | 恩福莱克逊治疗有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-113660931-B | Arylaniline and heteroaryl aniline compounds for the treatment of skin cancer | 恩福莱克逊治疗有限公司 | 2024-10-11 | — | — | CN | disclosed |